Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
Clinical trial NCT05176366 · TERMINATED
Trial details
- NCT number
- NCT05176366
- Sponsor
- Direct Biologics, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2024-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.